Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells

Biochemical Pharmacology

Volumn 44, Issue 2, 1992, Pages 223-229

  Heller, Regine ^a,b   Bussolino, Federico ^b   Ghigo, Dario ^b   Garbarino, Giovanni ^b   Pescarmona, Glanpiero ^c   Till, Uwe ^a   Bosia, Amalia ^b  

^a Academic Medical Centre   (Germany)

^b UNIVERSITY OF TURIN   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC GMP; ACYLTRANSFERASE; ARACHIDONIC ACID; CYCLIC GMP; ISOBUTYLMETHYLXANTHINE; LINSIDOMINE; MOLSIDOMINE; NITRO DERIVATIVE; NITROPRUSSIDE SODIUM; RADIOISOTOPE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; VASODILATOR AGENT;

ARTICLE; BIOSYNTHESIS; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

ACETYLTRANSFERASES; CELLS, CULTURED; CYCLIC GMP; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMAN; MOLSIDOMINE; NITROPRUSSIDE; PLATELET ACTIVATING FACTOR; SUPPORT, NON-U.S. GOV'T; THROMBIN;

EID: 0026772205     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(92)90004-3     Document Type: Article

References (40)

1. Endothelium-derived relaxing and contracting factors
2. The release of platelet-activating factor from human endothelial cells in culture
3. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin and adenosine triphosphate
4. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin
5. Perspectives in platelet-activating factor research
6. Platelet activating factor and related acetylated lipids as potent biologically active cellular mediators
7. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion
8. Leukotrienes in the cardiovascular system
9. Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron
10. Molecular aspects underlying the vasodilator action of molsidomine
11. Direct comparison of the effects of nitroprusside, SIN-1 and various nitrates on platelet aggregation and soluble guanylate cyclase activity
12. Endothelium removal augments vasodilation by sodium nitroprusside and sodium nitrite
13. Anti-ischemic actions of molsidomine by venous and large coronary dilatation in combination with antiplatelet effects
14. Cyclic GMP synthesis and function
15. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
16. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
17. Endothelial cells for studies of platelet-activating factor and arachidonate metabolites
18. Production of platelet-activating factor by chick retina
19. Release of arachidonic acid from vascular endothelial cells fatty acyl specificity is observed with receptor-mediated agonists and with the calcium ionophore A23187 but not with melittin
20. + exchange in thrombin-induced platelet-activating factor production by human endothelial cells
21. Inhibition of prostacyclin synthesis in endothelial cells by methylisobutylxanthine is not mediated through elevated cAMP level
22. Generation of NO from molsidomine (SIN-1) in vitro and its relationship to changes in coronary vessel tone
23. SIN-1 stimulates the production of cyclic GMP but not cyclic AMP in porcine aortic endothelial cells
24. The regulation of platelet-activating factor production in endothelial cells: the role of calcium and protein kinase C
25. Protein kinase C and cyclic AMP modulate thrombin-induced platelet-activating factor synthesis in human endothelial cells
26. Role of cyclic GMP in the mechanism of action of nitrovasodilators, endothelium-dependent agents and atrial natriuretic peptide
27. Evidence for the inhibitory role of guanosine 3′–5′-monophosphate in ADP induced human platelet aggregation in the presence of nitric oxide and related vasodilators
28. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites
29. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets
30. Nitroprusside differentially inhibits ADP-stimulated calcium influx and mobilization in human platelets
31. Effect of a stimulant of guanylate cyclase, SIN-1, on calcium movements and phospholipase C activation in thrombin-stimulated human platelets
32. Mechanism of cyclic GMP-dependent relaxation in vascular smooth muscle
33. Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells
34. Stoichiometric and reversible phosphorylation of a 46-KDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators
35. Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate
36. Synthesis of platelet-activating factor by endothelial cells: the role of G proteins
37. Cyclic GMP analogs inhibit gamma thrombininduced arachidonic acid release in human platelets
38. Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents
39. Subcellular localization of phospholipids and enzymes involved in PAF-acether metabolism
40. Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture